International news coverage for our biological age diagnostic
On the 7th of September 2015 an article featuring our ageing diagnostic technology was published in Genome Biology.
XRGenomics LTD CSO, Professor James Timmons, provided dozens of interviews explaining the vast number of application for 'biological age'. This includes identification of those most at risk of age-related disease, including dementia.
Technical note: it is critical to appreciate, this technology can be combined with 'disease-specific' variables to contribute to diagnosis, prognosis or to stratify patient recruitment into any clinical trial where, traditionally, birth year has been used as a risk or recuitment factor.
Times UK: Diagnosing health at age 60y
British journalise David Aaronovitch, reaches 60y of age and wonders how well he is ageing. The first person to take our 150-gene RNA-based ageing-diagnostic test, David reports on his experience in an article in the Sunday Times.
August 2015 - Michael Mosley put's our ageing research under the microscope.
Innovate UK award XRGenomics LTD with Innovation Voucher
May, 2015, XRGenomics LTD was provided with an Innovation voucher to support their ageing-diagnostic technology development
Affymetrix Inc features the CSO of XRGenomics LTD discussing the pros and cons of RNA detection technologies
In 1998, Dr Timmons designed one of the world’s first ‘personalised medicine’ projects, while working at Pfizer Inc. He chose to use Affymetrix gene-chip technology to try and explain the highly variable cardiovascular benefits of exercise therapy. Decades later, the latest gene-chips provide the most reproducible and comprehensive view of the human transcriptome in a format suitable for clinical diagnostic development.
BBC Horizon: The Truth About Exercise
Technology developed by XRGenomics scientists was feature in the critically acclaimed BBC documentary 'Horizon: The Truth About Exercise' which examined new developments public health and exercise science. The documentary has been viewed by over 20 million people, world-wide.